Bio-evaluation of doxorubicin (DOX)-incorporated hydroxyapatite (HAp)-chitosan (CS) nanocomposite triggered on osteosarcoma cells

[1]  Saikat Ghosh,et al.  Biomedical Application of Doxorubicin Coated Hydroxyapatite-Poly(lactide-co-glycolide) Nanocomposite for Controlling Osteosarcoma Therapeutics. , 2020, Journal of nanoscience and nanotechnology.

[2]  I. Banerjee,et al.  Development and physicochemical characterization of doxorubicin-encapsulated hydroxyapatite–polyvinyl alcohol nanocomposite for repair of osteosarcoma-affected bone tissues , 2019, Comptes Rendus Chimie.

[3]  E. Andrade,et al.  Planting and seasonal and circadian evaluation of a thymol-type oil from Lippia thymoides Mart. & Schauer , 2018, Chemistry Central Journal.

[4]  G. Buonocore,et al.  Chitosan-hydroxyapatite nanocomposites: Effect of interfacial layer on mechanical and dielectric properties , 2018, Materials Chemistry and Physics.

[5]  Murugan A. Munusamy,et al.  A phosphorylated chitosan armed hydroxyapatite nanocomposite for advancing activity on osteoblast and osteosarcoma cells , 2018 .

[6]  Saikat Ghosh,et al.  A Succinct Overview of Hydroxyapatite Based Nanocomposite Biomaterials: Fabrications, Physicochemical Properties and Some Relevant Biomedical Applications , 2018 .

[7]  C. Dass,et al.  Doxorubicin Action on Mitochondria: Relevance to Osteosarcoma Therapy? , 2018, Current Drug Targets.

[8]  Junjie Wang,et al.  Lignocellulose-Chitosan-Multiwalled Carbon Nanotube Composites with Improved Mechanical Strength, Dimensional Stability and Fire Retardancy , 2018, Polymers.

[9]  Rohini M. de Silva,et al.  Synthesis of multifunctional activated carbon nanocomposite comprising biocompatible flake nano hydroxyapatite and natural turmeric extract for the removal of bacteria and lead ions from aqueous solution , 2018, Chemistry Central Journal.

[10]  Vijjulatha Manga,et al.  Synthesis, anti-microbial activity, cytotoxicity of some novel substituted (5-(3-(1H-benzo[d]imidazol-2-yl)-4-hydroxybenzyl)benzofuran-2-yl)(phenyl)methanone analogs , 2018, Chemistry Central Journal.

[11]  Daniel J. Burnside,et al.  The sensitivity of the yeast, Saccharomyces cerevisiae, to acetic acid is influenced by DOM34 and RPL36A , 2017, PeerJ.

[12]  M. A. Nazeer,et al.  Intercalated chitosan/hydroxyapatite nanocomposites: Promising materials for bone tissue engineering applications. , 2017, Carbohydrate polymers.

[13]  D. Kaplan,et al.  Quantifying the efficiency of Hydroxyapatite Mineralising Peptides , 2017, Scientific Reports.

[14]  Huahua Yu,et al.  Effect of the molecular weight of water-soluble chitosan on its fat-/cholesterol-binding capacities and inhibitory activities to pancreatic lipase , 2017, PeerJ.

[15]  Kannan,et al.  Encapsulation of Doxorubicin in PLGA Nanoparticles Enhances Cancer Therapy , 2017 .

[16]  M. Rashidi,et al.  Doxorubicin loaded large-pore mesoporous hydroxyapatite coated superparamagnetic Fe3O4 nanoparticles for cancer treatment. , 2016, International journal of pharmaceutics.

[17]  Jianbo Xiao,et al.  Marine-derived bioactive compounds with anti-obesity effect: A review , 2016 .

[18]  L. Sukhodub,et al.  Injectable Biopolymer-hydroxyapatite Hydrogels: Obtaining and their Characterization , 2016 .

[19]  M. R. Talaie,et al.  A comparative study on non-covalent functionalization of carbon nanotubes by chitosan and its derivatives for delivery of doxorubicin , 2015 .

[20]  G. S. Martynková.  Preparation and Mechanical Properties of Polymeric Nanocomposites with Hydroxyapatite and Hydroxyapatite/Clay Mineral Fillers - Review , 2015 .

[21]  S. Saber-Samandari,et al.  Effect of Iron Substitution in Hydroxyapatite Matrix on Swelling Properties of Composite Bead , 2015 .

[22]  R. Zentel,et al.  Not just for tumor targeting: unmet medical needs and opportunities for nanomedicine. , 2015, Nanomedicine.

[23]  D. Mangalaraj,et al.  Core–shell hydroxyapatite/Mg nanostructures: surfactant free facile synthesis, characterization and their in vitro cell viability studies against leukaemia cancer cells (K562) , 2015 .

[24]  Wei Zhang,et al.  Reversal of multidrug resistance in MCF-7/Adr cells by codelivery of doxorubicin and BCL2 siRNA using a folic acid-conjugated polyethylenimine hydroxypropyl-β-cyclodextrin nanocarrier , 2015, International journal of nanomedicine.

[25]  H. Awad,et al.  Preparation and characterization of chitosan–hydroxyapatite–glycopolymer/Cloisite 30 B nanocomposite for biomedical applications , 2015, Polymer Bulletin.

[26]  Naveen Nagiah,et al.  Fabrication and evaluation of (PVA/HAp/PCL) bilayer composites as potential scaffolds for bone tissue regeneration application , 2014 .

[27]  K. Gross,et al.  Effect of processing conditions on the crystallinity and structure of carbonated calcium hydroxyapatite (CHAp) , 2014 .

[28]  M. Kowshik,et al.  Antimicrobial activity of hemocompatible silver doped hydroxyapatite nanoparticles synthesized by modified sol–gel technique , 2014, Applied Nanoscience.

[29]  A. Merkoçi,et al.  Nano-assembled supramolecular films from chitosan-stabilized gold nanoparticles and cobalt(II) phthalocyanine , 2013 .

[30]  Jin-Oh You,et al.  A drug-delivery vehicle combining the targeting and thermal ablation of HER2+ breast-cancer cells with triggered drug release. , 2013, Angewandte Chemie.

[31]  M. Dadsetan,et al.  Controlled release of doxorubicin from pH-responsive microgels. , 2013, Acta biomaterialia.

[32]  A. Mansur,et al.  Functionalized-chitosan/quantum dot nano-hybrids for nanomedicine applications: towards biolabeling and biosorbing phosphate metabolites. , 2013, Journal of materials chemistry. B.

[33]  Meifang Zhu,et al.  Antitumor efficacy of doxorubicin-loaded electrospun nano-hydroxyapatite–poly(lactic-co-glycolic acid) composite nanofibers , 2013 .

[34]  T. Imae,et al.  Fabrication and characterization of dendrimer-functionalized mesoporous hydroxyapatite. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[35]  M. Jahanshahi,et al.  Synthesis and characterization of hydroxyapatite/chitosan nanocomposite materials for medical engineering applications , 2012 .

[36]  D. Fawcett,et al.  Thermal and ultrasonic influence in the formation of nanometer scale hydroxyapatite bio-ceramic , 2011, International journal of nanomedicine.

[37]  J. Locs,et al.  Release of Anticancer Drug Doxorubicin from Biodegradable Polymer Coated Porous Hydroxyapatite Scaffolds , 2011 .

[38]  Tina Hernandez-Boussard,et al.  Doxorubicin pathways: pharmacodynamics and adverse effects , 2011, Pharmacogenetics and genomics.

[39]  R. Ramanujan,et al.  Doxorubicin loaded PVA coated iron oxide nanoparticles for targeted drug delivery , 2010 .

[40]  R. Misra,et al.  Controlled and extended drug release behavior of chitosan-based nanoparticle carrier. , 2010, Acta biomaterialia.

[41]  I. Banerjee,et al.  Chemical Synthesis, Characterization, and Biocompatibility Study of Hydroxyapatite/Chitosan Phosphate Nanocomposite for Bone Tissue Engineering Applications , 2009, International journal of biomaterials.

[42]  S. Mohapatra,et al.  Chemical synthesis and characterization of hydroxyapatite (HAp)-poly (ethylene co vinyl alcohol) (EVA) nanocomposite using a phosphonic acid coupling agent for orthopedic applications , 2009 .

[43]  P. Pramanik,et al.  Synthesis and Characterization of Hydroxyapatite/ Poly(Vinyl Alcohol Phosphate) Nanocomposite Biomaterials , 2008 .

[44]  R. Tang,et al.  Role of hydroxyapatite nanoparticle size in bone cell proliferation , 2007 .

[45]  A. Tarafdar,et al.  Capping agent-assisted synthesis of nanosized hydroxyapatite: Comparative studies of their physicochemical properties , 2007 .

[46]  S. Mohapatra,et al.  Processing and Properties of Nano-Hydroxyapatite(n-HAp)/Poly(Ethylene-Co-Acrylic Acid)(EAA) Composite Using a Phosphonic Acid Coupling Agent for Orthopedic Applications , 2007 .

[47]  D. Kalyon,et al.  Biocomposites of nanohydroxyapatite with collagen and poly(vinyl alcohol). , 2006, Colloids and surfaces. B, Biointerfaces.

[48]  Zi-rong Xu,et al.  In vitro effects of chitosan nanoparticles on proliferation of human gastric carcinoma cell line MGC803 cells. , 2005, World journal of gastroenterology.

[49]  M. Adams.  Salvage treatment for ovarian cancer. , 1990, Clinical oncology (Royal College of Radiologists (Great Britain)).